For an extended 1-week, 1-month or 3-month treatment of cancers, the Bio-MM DDS is applied to incorporate the drug into...
More Info
Bio-NN Nanoparticle Controlled-Release Injectable DDS technology is using liposome-encapsulated or albumin-bound drugs for prolonged bio half-life...
More Info
Bio-D3 Target Delivery Transdermal DDS technology is employed with proprietary Bio-D3 skin penetration enhancers to develop...
More Info
As an innovative dosage form principally for sublingual or oral cavity absorption, Orally Dissolving Film (“ODF”) is formulated...
More Info
Bio-CR Oral Controlled-Release DDS technology is incorporated with captive API of proprietary manufacturing process and/or proprietary crystalline forms...
More Info